Previous close | 125.69 |
Open | 127.22 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 126.00 - 128.21 |
52-week range | 71.57 - 141.39 |
Volume | |
Avg. volume | 1,554 |
Market cap | 215.273M |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 0.15 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Masimo's (MASI) R&D activities raise optimism about the stock.
CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.
GE HealthCare (GEHC) announces its latest AI-powered Voluson Signature 20 and 18 ultrasound systems, which are likely to provide effective and efficient care for conditions impacting women's health.